Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board

Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board

Douglas P. Zipes MD Editor-in-Chief

See All Experts

featured

Published in Cardiology

Journal Scan / Research · May 31, 2016

Tocilizumab Improves Inflammation in Patients With Non-STEMI

European Heart Journal

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

The Pivotal Position of IL-6 in the Pathogenesis of Ischemic Heart Disease, and a Lot of New Questions

Disclosure statements are available on the authors' profiles:

Peter Libby MD

European Heart Journal

Effect of a Single Dose of the Interleukin-6 Receptor Antagonist Tocilizumab on Inflammation and Troponin T Release in Patients With Non-ST-Elevation Myocardial Infarction: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

Eur Heart J 2016 May 08;[EPub Ahead of Print], O Kleveland, G Kunszt, M Bratlie, T Ueland, K Broch, E Holte, AE Michelsen, B Bendz, BH Amundsen, T Espevik, S Aakhus, JK Damås, P Aukrust, R Wiseth, L Gullestad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Tocilizumab Improves Inflammation in Patients With Non-STEMI

Additional Info

Effect of a Single Dose of the Interleukin-6 Receptor Antagonist Tocilizumab on Inflammation and Troponin T Release in Patients With Non-ST-Elevation Myocardial Infarction: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

Further Reading

Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With LV Hypertrophy

Update on the Diagnosis and Management of Kawasaki Disease

Effect of Aficamten on Health Status Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy

Long-Term Outcomes After Stress Echocardiography in Real-World Practice

Proteomics for the Prediction of Different Cardiovascular Diseases and Dementia

2024 American Heart Association and American Red Cross Guidelines for First Aid

Unipolar Voltage Mapping to Predict LVEF Recovery in Patients With Recent-Onset Nonischemic Cardiomyopathy

Updated Consensus on CPR and Emergency Cardiovascular Care Science With Treatment Recommendations

Improving Balloon Pulmonary Angioplasty Through Target Endpoint Optimization With Pressure Catheter and Angiographic Lung Perfusion

Implications of Arrhythmogenic Features of QRS Fragmentation in Patients With Cardiomyopathy

Coronary Plaque Radiomic Phenotypes Predict Fatal or Nonfatal Myocardial Infarction

Recently Updated